SLN
Silence Therapeutics PlcstockNASDAQADR
Market OpenNov 19, 2026 3:14:28 PM EST
19.82USD-0.025%(-0.00)94,900
Pre-marketNov 19, 2026 8:00:30 AM EST
19.87USD+0.252%(+0.05)
SLN Financials
In Q3 FY 2026 (ended ), Silence Therapeutics Plc (SLN) reported revenue of $0, net income of −$12.43M, operating cash flow of −$12.78M, and assets of $281.5M (filed ).
Loading business breakdowns…